These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 39168094)
21. Early Cancer Biomarker Discovery Using DIA-MS Proteomic Analysis of EVs from Peripheral Blood. Espejo C; Lyons B; Woods GM; Wilson R Methods Mol Biol; 2023; 2628():127-152. PubMed ID: 36781783 [TBL] [Abstract][Full Text] [Related]
22. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. Zheng X; Xu K; Zhou B; Chen T; Huang Y; Li Q; Wen F; Ge W; Wang J; Yu S; Sun L; Zhu L; Liu W; Gao H; Yue L; Cai X; Zhang Q; Ruan G; Zhu T; Wu Z; Zhu Y; Shao Y; Guo T; Zheng S J Extracell Vesicles; 2020; 9(1):1750202. PubMed ID: 32363013 [No Abstract] [Full Text] [Related]
23. Untargeted multi-omic analysis of colorectal cancer-specific exosomes reveals joint pathways of colorectal cancer in both clinical samples and cell culture. Eylem CC; Yilmaz M; Derkus B; Nemutlu E; Camci CB; Yilmaz E; Turkoglu MA; Aytac B; Ozyurt N; Emregul E Cancer Lett; 2020 Jan; 469():186-194. PubMed ID: 31669517 [TBL] [Abstract][Full Text] [Related]
24. Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis. Shi X; Zhao X; Xue J; Jia E BMC Cancer; 2024 May; 24(1):623. PubMed ID: 38778252 [TBL] [Abstract][Full Text] [Related]
25. Tumor-derived exosomal miRNA-320d as a biomarker for metastatic colorectal cancer. Tang Y; Zhao Y; Song X; Song X; Niu L; Xie L J Clin Lab Anal; 2019 Nov; 33(9):e23004. PubMed ID: 31420913 [TBL] [Abstract][Full Text] [Related]
26. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer. Shi Y; Zhuang Y; Zhang J; Chen M; Wu S Tissue Cell; 2021 Jun; 70():101499. PubMed ID: 33550035 [TBL] [Abstract][Full Text] [Related]
27. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer. Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555 [TBL] [Abstract][Full Text] [Related]
28. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer. Bhardwaj M; Terzer T; Schrotz-King P; Brenner H Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402 [TBL] [Abstract][Full Text] [Related]
29. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors. Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368 [TBL] [Abstract][Full Text] [Related]
30. piRNA in Machine-Learning-Based Diagnostics of Colorectal Cancer. Li S; Kouznetsova VL; Kesari S; Tsigelny IF Molecules; 2024 Sep; 29(18):. PubMed ID: 39339306 [TBL] [Abstract][Full Text] [Related]
31. Metabolic phenotyping to monitor chronic enteritis canceration. Zhang F; Li C; Deng K; Wang Z; Zhao W; Yang K; Yang C; Rong Z; Cao L; Lu Y; Huang Y; Han P; Li K Metabolomics; 2020 Feb; 16(3):29. PubMed ID: 32095917 [TBL] [Abstract][Full Text] [Related]
32. Identification of faecal extracellular vesicles as novel biomarkers for the non-invasive diagnosis and prognosis of colorectal cancer. Zhang Z; Liu X; Yang X; Jiang Y; Li A; Cong J; Li Y; Xie Q; Xu C; Liu D J Extracell Vesicles; 2023 Jan; 12(1):e12300. PubMed ID: 36604402 [TBL] [Abstract][Full Text] [Related]
33. High-Throughput Omics and Statistical Learning Integration for the Discovery and Validation of Novel Diagnostic Signatures in Colorectal Cancer. Long NP; Park S; Anh NH; Nghi TD; Yoon SJ; Park JH; Lim J; Kwon SW Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642095 [TBL] [Abstract][Full Text] [Related]
34. Models of logistic regression analysis, support vector machine, and back-propagation neural network based on serum tumor markers in colorectal cancer diagnosis. Zhang B; Liang XL; Gao HY; Ye LS; Wang YG Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323037 [TBL] [Abstract][Full Text] [Related]
35. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis. Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353 [TBL] [Abstract][Full Text] [Related]
36. Extracellular vesicles-derived CXCL4 is a candidate serum tumor biomarker for colorectal cancer. Xie J; Xing S; Jiang H; Zhang J; Li D; Niu S; Huang Z; Yin H iScience; 2024 Apr; 27(4):109612. PubMed ID: 38632995 [TBL] [Abstract][Full Text] [Related]
37. Blood Biomarkers Panels for Screening of Colorectal Cancer and Adenoma on a Machine Learning-Assisted Detection Platform. Wang H; Zhou Z; Li H; Xiang W; Lan Y; Dou X; Zhang X Cancer Control; 2023; 30():10732748231222109. PubMed ID: 38146088 [TBL] [Abstract][Full Text] [Related]
38. Identification of a circulating microRNA signature for colorectal cancer detection. Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885 [TBL] [Abstract][Full Text] [Related]
39. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer. Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169 [TBL] [Abstract][Full Text] [Related]
40. Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia. Aparicio P; Navarrete-Villanueva D; Gómez-Cabello A; López-Royo T; Santamaría E; Fernández-Irigoyen J; Ausín K; Arruebo M; Sebastian V; Vicente-Rodríguez G; Osta R; Manzano R J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1883-1897. PubMed ID: 39009419 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]